LCN2 and obesity due to melanocortin 4 receptor deficiency: Human studies have demonstrated that higher circulating LCN2 levels are associated with obesity, insulin resistance, and dyslipidemia in T2D patients, thereby proposing LCN2 as a serum marker for metabolic disorders [106,107].